During the past decade, Ataturk University Faculty of Medicine Pulmonary Disease Department conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ataturk University Faculty of Medicine Pulmonary Disease Department" are "Chronic Obstructive Pulmonary Disease" (1 trials) and "This Study Will Provide Data Comparing Safety of LMWH Versus UFH in the Treatment of Acute PE Cases Who Require Thrombolytic Treatment." (1 trials). Many other conditions were trialed in "Ataturk University Faculty of Medicine Pulmonary Disease Department" in a lesser frequency.

Most popular intervention types in "Ataturk University Faculty of Medicine Pulmonary Disease Department" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Budesonide 4 mg" (1 trials), "Budesonide 8 mg" (1 trials), "Metil prednisolone" (1 trials) and "enoxaparin ,alteplase, unfractionated heparin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ataturk University Faculty of Medicine Pulmonary Disease Department" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Ataturk University Faculty of Medicine Pulmonary Disease Department". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Ataturk University Faculty of Medicine Pulmonary Disease Department, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ataturk University Faculty of Medicine Pulmonary Disease Department, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".